5NE3 | Hydrolase Inhibitor | date | Mar 09, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | L2 Class A Serine-Beta-Lactamase Complexed With Avibactam | ||||||||||||||
authors | P.Hinchliffe, K.Calvopina, J.Spencer | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Beta-Lactamase Chain: A, B Synonym: L2 Class A Serine-Beta-Lactamase Ec: 3.5.2.6 Engineered: Yes |
Organism_scientific: Stenotrophomonas Maltophilia K279a Organism_taxid: 522373 Gene: Smlt3722 Expression_system: Escherichia Coli Bl21 Expression_system_taxid: 511693 Expression_system_variant: Solubl21 Expression_system_vector_type: Plasmid Expression_system_plasmid: Popin-F | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.35 Å | ||||||||||||
ligand | NXL | enzyme | Hydrolase E.C.3.5.2.6 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structural/mechanistic insights into the efficacy of non-classical beta-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates., Calvopina K, Hinchliffe P, Brem J, Heesom KJ, Johnson S, Cain R, Lohans CT, Fishwick CWG, Schofield CJ, Spencer J, Avison MB, Mol Microbiol. 2017 Sep 6. doi: 10.1111/mmi.13831. PMID:28876489 |
Data retrieval |
View 5NE3 in 3D |
Visual 3D analysis of 5NE3 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5NE3 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |